Logo
driftfg
Altria Group (NYSE:MO) sells cigarettes, oral nicotine pouches, and vapor products to adult tobacco users in the US. It's the parent of Marlboro, still the country's top-selling cigarette brand. The stock showed up in Donald Trump's disclosed portfolio, and it's easy to see the appeal: over 50 straight years of dividend increases and a business that doesn't move much with the economic cycle.
Altria stock is up around 25% year to date. Over the trailing 12 months, the stock is up about 24%, ahead of the market's 19% gain. Only Philip Morris, up 21% YTD, comes close among the major tobacco names. British American Tobacco and ***** an Tobacco are each up 10%.
Altria's Q1 2026 earnings beat expectations on both lines. Net revenue grew 3.2% year over year mostly from pricing, not volume. Adjusted diluted EPS grew 7.3%, up from 4.4% growth in 2025.
The volume story is also improving. Altria's smokeable segment declined just 4% in Q1 2026, down sharply from a 12% decline a year earlier. On the oral tobacco side, on! PLUS nicotine pouches rolled out nationwide in March and are now in roughly 100,000 stores, covering 85% of the nicotine pouch category by volume. On!'s own volume grew 17.6% year-over-year in Q1, after growing 11% for all of 2025. It's also the first product authorized under the FDA's streamlined pilot review program for oral nicotine pouches.
Valuation

#tobacco #oral #grew #group
2 months ago

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from driftfg , click on at the bottom under it